Xufeng Lu
Impact in
-
- Liver physiology and pathology
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Histone Deacetylase Inhibitors Research 2
-
- Nanoplatforms for cancer theranostics 4
- Co-authors
- Hong Bu (7 shared papers)Yongjie Zhou (6 shared papers)Yujun Shi (6 shared papers)Hongjie Ji (5 shared papers)Zhenru Wu (3 shared papers)Qing Xu (1 shared paper)Xiang Zhuang (1 shared paper)Yongjie Zhu (2 shared papers)
- Journals
- Materials Today Bio (2 papers)Advanced Science (1 paper)Journal of Hepatology (1 paper)Liver International (1 paper)Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesNepal
In The Last Decade
Xufeng Lu
16 papers receiving 382 citations
Xufeng Lu's Hit Papers
Peers
Comparison fields: 5 of 75
- Hepatology 37
- Cancer Research 56
- Molecular Biology 143
- Biomaterials 26
- Immunology 33
Countries citing papers authored by Xufeng Lu
This map shows the geographic impact of Xufeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xufeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xufeng Lu more than expected).
Fields of papers citing papers by Xufeng Lu
This network shows the impact of papers produced by Xufeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xufeng Lu. The network helps show where Xufeng Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xufeng Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 127 | |
| 2 | Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy Hit paper breakdown → | 2024 | 107 |
| 3 | 2015 | 22 | |
| 4 | 2022 | 21 | |
| 5 | 2015 | 20 | |
| 6 | 2016 | 19 | |
| 7 | 2024 | 18 | |
| 8 | 2015 | 9 | |
| 9 | Cellular and molecular biology of hepatocyte growth, regeneration and gene expression. | 1990 | 9 |
| 10 | 2023 | 7 | |
| 11 | 2015 | 7 | |
| 12 | 2025 | 6 | |
| 13 | 2025 | 5 | |
| 14 | 2017 | 4 | |
| 15 | 2025 | 1 | |
| 16 | 2017 | 1 |
About Xufeng Lu
Xufeng Lu is a scholar working on Molecular Biology, Biomedical Engineering, Oncology, Cancer Research and Surgery, having authored 16 papers that have together received 383 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (4 papers), Advanced Nanomaterials in Catalysis (2 papers), Metal-Organic Frameworks: Synthesis and Applications (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Liver physiology and pathology (2 papers), MicroRNA in disease regulation (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper) and Inflammatory Biomarkers in Disease Prognosis (1 paper). The work is most often cited by research in Hepatology (37 citations), Cancer Research (56 citations), Molecular Biology (143 citations), Biomaterials (26 citations) and Immunology (33 citations). Xufeng Lu has collaborated with scholars based in China, United States and Nepal. Frequent co-authors include Hong Bu, Yongjie Zhou, Yujun Shi, Hongjie Ji, Zhenru Wu, Qing Xu, Xiang Zhuang, Yongjie Zhu, Mingyang Shao and Xiaoyue Cao. Their work appears in journals such as Materials Today Bio, Advanced Science, Journal of Hepatology, Liver International and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.